Prognostic Variables in Node-Negative and Node-Positive Breast Cancer - Rilegato

Rilegato

ISBN 10: 0792384474 ISBN 13: 9780792384472

Casa editrice: Kluwer Academic Pub, 1999

Riassunto

During the last decade, important advancements on the understanding of the molecular mechanisms involved in tumorigenesis and progression of breast cancer have been made, particularly regarding the mechanisms of control of the cell cycle, apoptosis, metastasis, and angiogenesis. Translation of basic research to the clinical setting by the identification of assessable markers associated with the above biological mechanisms has permitted verification of the clinical significance of several prognostic indicators and has highlighted the heterogeneous nature of invasive breast cancer.Reprinted from Breast Cancer Research And Treatment, this text contains original papers, overviews, and position papers on the methodological aspects and the clinical significance of the more interesting prognostic and predictive indicators. Ultimately, the determination of biological prognostic and predictive markers with easily applicable, reproducible, and standardizable assays is an integral part of future research aimed to improve the management of patients operated for breast cancer in the years to come. Novel therapeutic strategies based not only on chemotherapy or hormone therapy, but directed at interfering with the molecular targets involved in tumor progression and metastasis, warrant clinical testing and are a major challenge to enhance the potential cure of breast cancer.

Su questo libro

Contenuti

Prognostic variables in node-negative and node-positive breast cancer - Introduction; G. Gasparini. Routinely available indicators of prognosis in breast cancer; D.L. Page, et al. Prognostic factors for patients with breast cancers 1cm and smaller; Y.-Y. Chen, S.J. Schnitt. Steroid hormone receptors in breast cancer management; C.K. Osborne. S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer; J. Bryant, et al. S-phase fraction and breast cancer - a decade of experience; C.R. Wenger, G.M. Clark. Prognostic and predictive value of thymidine labelling index in breast cancer; D. Amadori, R. Silvestrini. Cyclin D1 in breast cancer; D.M. Barnes, C.E. Gillett. Cyclins and breast cancer; P.S. Steeg, Q. Zhou. Prognostic implications of expression of the cell cycle inhibitor p27Kip1; S. Cariou, et al. The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer; W.J. Gullick, R. Srinivasan. c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients; S. De Placido, et al. HER-2/neu as a predictive marker of response to breast cancer therapy; M.D. Pegram, et al. Prognostic and predictive value of p53 and p21 in breast cancer; R.M. Elledge. The urokinase plasminogen activator system as a target for prognostic studies in breast cancer; R.W. Stephens, et al. Metalloproteinases and tissue inhibitors of metalloproteinases; M. Toi, et al. Matrix metalloproteinase inhibitors; P.D. Brown. The 67 kDa laminin receptor as a prognostic factor in human cancer; S. Ménard, et al. Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis; R. Heimann, et al.Clinical significance of angiogenic factors in breast cancer; N. Locopo. Insulin-like growth factors in human breast cancer; M.J. Ellis, et al. Molecular prognostic markers in breast cancer; R. Dahiya, G. Deng. Prognostic significance of micrometastatic bone marrow involvement; S. Braun, K. Pantel. Timing of surgery for primary breast cancer with regard to the menstrual phase and prognosis; I. Jatoi. Time-dependence of hazard ratios for prognostic factors in primary breast cancer; S.G. Hilsenbeck, et al. Circulating tumors markers in breast cancer. Accepted utilities and novel prospects; V. Stearns, et al. The relationship between prognostic and predictive factors in the management of breast cancer; I.C. Henderson, A.J. Patek. Methodological challenges in the evaluation of prognostic factors in breast cancer; D.G. Altman, G.H. Lyman. Assessing the clinical impact of prognostic factors: When is `statistically significant' clinically useful? D.F. Hayes, et al. Prognostic variables in node-negative and node-positive breast cancer &endash; editorial; G. Gasparini. Author index. Subject index.

Product Description

Book by None

Dettagli dell'edizione

• Editore: Kluwer Academic Pub
• Data di pubblicazione: 1999
• Lingua: Inglese
• ISBN 10: 0792384474
• ISBN 13: 9780792384472
• Rilegatura: Copertina rigida
• Numero di pagine: 440
• Redattore: Gasparini Giampietro M.D.
• Contatto del produttore: Springer Nature Customer Service Center GmbH; ProductSafety@springernature.com; ; Europaplatz 3; Heidelberg; 69115; Germania